Hashimoto's disease itself is not a contraindication to GLP-1 receptor agonist use
PlexusDx offers tirzepatide injection at $289/mo month-to-month, or from $249/mo on the 6-month plan, positioning it as a direct alternative to dual-agent experimentation
Medicare covers GLP1s+ only to treat patients with diabetes or patients with obesity if they have diagnosed cardiovascular disease Only 18 states cover anti-obesity medications for Medicaid patients Less than 50% of commercial plans cover GLP1s for obesity, and those that do often impose unreasonable hurdles on coverage Cash pay prices are $1000-$1500/month (without savings cards) Cash pay with savings card is at least $550 for Zepbound and $650 for Wegovy Ive written about the lack of coverage here
Gn ierisinde de bol su iilmesi nerilir
For most readers, the real question is not Which one is stronger? but Which one fits my life, my stomach, my goals, and my budget? That is the right question, because the best medicine is the one a person can take correctly and consistently [3]
So realistically, if you've written down that the mortgage rate is 6.5 percent right now, our view probably doesn't change things too much